ILCA Virtual.
11-13 September.
For everyone researching and treating liver cancer.

Enjoy a daily live stream, 50+ sessions of original thinking, inspiration and complimentary access to exclusive on-demand sessions

Save your spot!

Symposium on Cancer Care beyond Anti-tumor Therapy with 

Florian Strasser, Head of Integrated Oncological Rehabilitation at Klinik Gais AG, Switzerland, and Senior Consultant Clinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland

Maria Die Trill, Coordinator of the Psycho-Oncology Unit of the Hospital Universitario Gregorio Marañón and Assistant Professor at the School of Psychology, Universidad Complutense of Madrid, Spain

Psychosocial issues affect liver cancer patients at all stages of disease and their families, and lead to increased levels of anxiety and depression that adversely affect quality of life. PSYCHOONCOLOGY allows us to provide multidisciplinary, patient-centered care in the context of a life-threatening disease.

– Maria Die Trill

Get more insights about this on-demand symposium and learn about the speakers HERE

Follow the LIVE Symposium Question & Answer Session on Saturday, September 12 from 4:55 PM CEST to 5:10 PM CEST.

Benefit from the ILCA 2020 Virtual Conference Educational Grant

If you are a student or a trainee in the liver cancer field, you can benefit from an Educational Grant to attend the ILCA 2020 Virtual Conference and receive 1-year free ILCA membership. Interested in this opportunity? Then send us an email to [email protected]

Incyte – Sponsored Industry Symposium 

We are delighted to invite you to Incyte’s educational satellite symposium ‘Personalised Approaches in Cholangiocarcinoma’
Join our esteemed faculty as they discuss how cholangiocarcinoma represents a molecularly diverse subgroup of biliary tract cancers and explore the future direction of precision medicine.

The introduction of next-generation sequencing technologies has opened new horizons for a better understanding of the molecular basis of cholangiocarcinoma, and for the identification and evaluation of potential new treatments tailored to the molecular characteristics of patients’ tumours.1

During this symposium, our faculty will discuss the clinical and genetic heterogeneity in cholangiocarcinoma and their potential relevance to disease management. Key considerations, challenges and opportunities associated with the different technologies used for diagnosis and molecular profiling will be explored. Finally, our faculty will provide an overview of evolving treatment strategies, including targeted approaches. Interactivity will be encouraged during the live Q&A session.

1. Simile MM, et al. Medicina (Kaunas). 2019;55:42.
A virtual educational event organised and sponsored by Incyte Biosciences International

Date of preparation: July 2020
BE/OTHR/M/20/0003
© 2020, Incyte Biosciences International Sàrl. All rights reserved.

Principal Partners

Conference Partners and Supporters